Minovia Therapeutics Ltd.

Other

Protein Forest, Inc.

Cellect Technologies Corp.

Sonata Technologies Ltd.

Bioactivity Partnership

Zilberstein, Gleb

Bukshpan, Shmuel

Shmuel Bukshpan

Uriel Halavee

Natalie Yivgi Ohana

Moriya Blumkin

Noa Sher

Gleb Zilberstein

Arie Heiman

Natalie Yivgi-Ohana

Gleb Zilbertstein

The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating brain diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.

Mitochondrial augmentation therapy of brain diseases

The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating renal diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.

Mitochondrial augmentation therapy of renal diseases

The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating ocular diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.

Mitochondrial augmentation therapy of ocular diseases

The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating muscle diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.

Mitochondrial augmentation therapy of muscle diseases

The present invention relates to compositions and methods of inducing angiogenesis and methods of treating a pathology that would benefit from angiogenesis by use of a composition comprising partially purified intact mitochondria and/or ruptured mitochondria derived therefrom.

Compositions and methods for inducing angiogenesis

A biometric device that may include a sensor that reacts to a chemical element associated with a sweat gland; wherein when the sensor is contacted by an area of a skin of a person, an image that comprises information about locations of sweat glands within the area of the skin of the person is generated by the sensor; an image processor that is configured to generate an authentication result by comparing between (a) the information of the image generated by the sensor and (b) reference information of locations of sweat glands of a given person; wherein the authentication result indicates whether the person is the given person; and a communication module for communicating an authentication result indication.

Sweat pores imaging method and device

The present invention relates to methods and apparatus for promoting rapid formation of biomolecule crystals from a solution of biomolecules, preferably proteins, wherein the protein solution undergoes rapid concentration according to its isoelectric point in an electric field. Protein crystallization according to the methods of the present invention takes place within a period of hours or less.

Methods and apparatus for rapid crystallization of biomolecules

The present invention relates to matrixes, arrays, systems and methods for analyzing biomolecules by their isoelectric point, optionally, in combination with a second dimension analysis. The assortment of matrixes, arrays and systems provided herein are useful for causing a biomolecule under the influence of an electrical field to accumulate into an buffer that comprises a pH value that is the same as the isoelectric point of the biomolecule. The methods of this invention are useful for, e.g., research and diagnostic purposes.

Matrixes, arrays, systems and methods

We disclose methods of sorting or separating mixtures of living cells (e.g., eukaryotic, prokaryotic, mammalian, pathogenic, bacterial, viral, etc.). We perform our methods by activating cell-selective photophoric labels, which photosensitize and chemically reduce a photosensitive metal compound to form metal grains, particles or crystals. The metal adheres to the cells and forms the basis for sorting or separating different cell types. Photophoric labels may include chemiluminescent agents such as peroxidase enzymes activated with peroxidase substrates capable of luminescence. Photosensitive metal compounds may be present in a light-sensitive matrix or emulsion containing photosensitizable metal compounds, which form metal grains, particles or crystals upon exposure to a developer solution. Developer solutions are formulated to substantially allow living cells to remain viable after exposure to the developing solution. Our methods are useful in flow cytometry and fluorescence activated cell sorting (FACS) methods, microdissection methods, and for attracting, sedimenting, depositing, layering, attaching, adhering, bonding, binding, trapping or suspending cells on surfaces.

Method for sorting and separating living cells

The present invention relates to matrixes, arrays, systems and methods for analyzing biomolecules by their isoelectric point, optionally, in combination with a second dimension analysis. The assortment of matrixes, arrays and systems provided herein are useful for causing a biomolecule under the influence of an electrical field to accumulate into an IEF buffer that comprises a pH value that is the same as the isoelectric point of the biomolecule. The methods of this invention are useful for, e.g., research and diagnostic purposes.

A method and apparatus for achieving ultrasonic coronary thrombolysis. After intravenous injection of a thrombus-specific ultrasound contrast agent, an array of ultrasonic transducers arranged in a pad placed on the patient's chest transmits ultrasound signals into the patient, from a virtual source. Reflected signals are then analyzed to determine the ratio of the second (or hall) harmonic to first harmonic components in the signals. A high ratio indicates the presence of a thrombus in the field of interrogation Time-of-flight data for each of the receivers is used to calculate a spatial location of the thrombus, and a phased array ultrasonic transmission is then focused on the thrombus, so as to achieve sonoparation.

Growing community of inventors

Ramat Hasharon, Israel

Shmuel Bukshpan